Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.

Journal of neural transmission (Vienna, Austria : 1996) - 1 May 2009

Shahabi H Niazi, Westberg L, Melke J, Håkansson A, Belin A Carmine, Sydow O, Olson L, Holmberg B, Nissbrandt H

Abstract excerpt

Cytochrome P450 2E1 (CYP2E1), which inter alia is located in dopamine containing neurons in the substantia nigra, has been hypothesized to be of importance for the pathophysiology of Parkinson's disease (PD), either by its production of reactive oxygen species (ROS) or by its capability to detoxify putative neurotoxins. Numerous polymorphisms in the coding and non-coding regions of the gene for this enzyme have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2E1

Share to Genetic Markers

Share to Genetic Testing

Share to Linkage Disequilibrium

Share to Parkinson Disease

Share to Sweden

Source

Identifiers

PMID: 19381774
DOI: 10.1007/s00702-009-0221-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytochrome P450 2E1 gene polymorphisms/haplotypes and Parkinson's disease in a Swedish population.PMID 19381774Read ↗

Genetic polymorphism of the CYP2E1 gene and susceptibility to Parkinson's disease in Taiwanese.Semantic proximity Read ↗

APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.Semantic proximity Read ↗

Genomic and pharmacogenomic biomarkers of Parkinson's disease.Semantic proximity Read ↗

Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.Semantic proximity Read ↗

Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease.Semantic proximity Read ↗

P450 enzymes and Parkinson's disease: the story so far.Semantic proximity Read ↗

Parkinson’s Disease Pharmacogenomics: New Findings and PerspectivesSemantic proximity Read ↗

Genotyping of CYP2D6 in Parkinson's disease.Semantic proximity Read ↗

Leads from xenobiotic metabolism genes for Parkinson's disease among north Indians.Semantic proximity Read ↗

Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.Semantic proximity Read ↗

Polymorphism in environment responsive genes and association with Parkinson disease.Semantic proximity Read ↗

An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.